Regeneron is a biopharmaceutical company that discovers, develops, and intends to commercialize therapeutic medicines for the treatment of serious medical ...www.regeneron.com

Regeneron Pharmaceuticals, Inc. currently markets ARCALYST™ (rilonacept) Injection for Subcutaneous Use for the treatment of a rare, inherited, ...www.regeneron.com

Regeneron Pharmaceuticals, Inc. (REGN)'s ARCALYST(R) (rilonacept) Reduced Incidence of Gout Flares by 81 Percent in a Phase 2 Study in Gout Patients ...www.biospace.com

See the company profile for Regeneron Pharmaceuticals, Inc. (REGN) including business summary, industry/sector information, number of employees, ...biz.yahoo.com

Regeneron Pharmaceuticals Inc. Completed. 11/15/2006. Follow-on. $175028000. $23.03. $1497706121. Regeneron Pharmaceuticals Inc. Completed. 10/12/2001 ...www.biocentury.com

Nov 12, 2008 ... Zacks Analyst Blog Highlights: Coca-Cola Hellenic Bottling Co., Regeneron Pharmaceuticals, Inc., Denbury Resources Inc., Kinross Gold Corp. ...finance.myfoxla.com

Home > Case Information > Class Notices > Regeneron Pharmaceutical... REGENERON PHARMACEUTICALS, INC. Join a Case · Report a Fraud · Join Our E-Mail List ...www.milberg.com

Regeneron Pharmaceuticals, Inc. Add to My Watchlist, (NSDQ: REGN) ... Regeneron Pharmaceuticals (REGN) Reports Results from Phase 2 Study of VEGF Trap-Eye ...studio-5.financialcontent.com